Clinical Trials in Minneapolis

Showing 2221-2240 of 12,418 trials

Prophylactic Antibiotics in Cystectomy With Diversion

NCT06190197

Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral antibiotic, nitrofurantoin, through comparison of rates of postoperative urinary tract infections within the 90-day postoperative period in patients with muscle invasive bladder cancer who undergo radical cystectomy with urinary diversion.

Muscle-Invasive Bladder CarcinomaRadical CystectomyIleal Conduit+1 more

University of Minnesota120 participantsStarted May 2024

Minneapolis, Minnesota, United States

Active Not Recruiting77 miles

Natural History Study Protocol in PMM2-CDG (CDG-Ia)

NCT03173300

Clinical and Basic Investigations into Phosphomannomutase deficiency (PMM2-CDG) This is a natural history (observational) protocol designed to collect clinical and biological information in patients with PMM2-CDG (CDG-Ia).

Phosphomannomutase 2 Deficiency

Glycomine, Inc.120 participantsStarted Jan 2018

Rochester, Minnesota, United States • Philadelphia, Pennsylvania, United States • Seattle, Washington, United States +8 more locations

Prophylactic Antibiotics in Cystectomy With Diversion

Natural History Study Protocol in PMM2-CDG (CDG-Ia)

Find Trials by Condition in Minneapolis

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

BRIGHT Coaching Program for Families

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

The Synergy Disc To Anterior Cervical Discectomy and Fusion

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors

Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)

Study of AVZO-021 in Patients With Advanced Solid Tumors

Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease

ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial

MARGetuximab Or Trastuzumab (MARGOT)